4Sabatine MS,Cannon CP,Gibson CM,et al.Addition of clopidogsel to aspirin and fibrinolytic therapy for myocardial in-farction with ST-segment elevation.N Engl J Med,2005,352(12):1179-1189.
5LauW,Carville D,Bates E.Clinical significance of the atorvastatin-clop idogrel drug-drug interaction.Circulation,2004,110(6):66-67.
6Mehta SR,Yusuf S,Peters RJ,et al.Effects of p retreatment with clop idogrel and asp irin followed by long-term the-rapy In patients undergoing percutaneous coronary intervention:The PCI-CURE study.Lancet,2001,358(9281):527-533.
7CAPRIE Steering,CommitteeA.Randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events.Lancet,I996.348:I329-1339.
8The CURE Trial Investigators.Effects of clopidogrel in addition to aspirin in patients with acute coron-syndromes without ST-elevation.N Engl J Med,2001,345:494-502.
9Muller I,Massberg S,ZierhutW,et al.Effects of asp irin andclop idogrel versus oral anticoagulation on p latelet function and on coagulation in patients with nonvalvular atrial fibrillation(CLAFIB).Pathophysiol Haemost Thromb,2002,32:16-24.
10BowryA,BrookhartM,ChoudhryNK.MetaAnalysis of the efficacy and safety of clop idogrel p lus asp irin as compared to antip latelet monotherapy for the p revention of vascular events.Am J Cardiol,2008,101(7):960-966.
